Clearside Biomedical
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CLSD and buy or sell other stocks, ETFs, and their options commission-free!About CLSD
Clearside Biomedical, Inc. is a biopharmaceutical company that delivers therapies to the back of the eye through the suprachoroidal space. Its SCS microinjector enables a simple, repeatable, in-office procedure to deliver treatments directly to the macula, retina, or choroid, potentially helping to preserve and improve vision in patients with serious eye diseases.
CEOGeorge M. Lasezkay, PharmD
CEOGeorge M. Lasezkay, PharmD
Employees32
Employees32
HeadquartersAlpharetta, Georgia
HeadquartersAlpharetta, Georgia
Founded2011
Founded2011
Employees32
Employees32
CLSD Key Statistics
Market cap4.71M
Market cap4.71M
Price-Earnings ratio-0.18
Price-Earnings ratio-0.18
Dividend yield—
Dividend yield—
Average volume1.50M
Average volume1.50M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$17.10
52 Week high$17.10
52 Week low$0.31
52 Week low$0.31
Stock Snapshot
As of today, Clearside Biomedical(CLSD) shares are valued at $0.90. The company's market cap stands at 4.71M, with a P/E ratio of -0.18.
On 2025-12-04, Clearside Biomedical(CLSD) stock opened at —, reached a high of —, and a low of —.
The Clearside Biomedical(CLSD)'s current trading volume is 0, compared to an average daily volume of 1.5M.
During the past year, Clearside Biomedical(CLSD) stock moved between $0.31 at its lowest and $17.10 at its peak.
During the past year, Clearside Biomedical(CLSD) stock moved between $0.31 at its lowest and $17.10 at its peak.
People also own
Based on the portfolios of people who own CLSD. This list is generated using Robinhood data, and it’s not a recommendation.